Export file:

Format

  • RIS(for EndNote,Reference Manager,ProCite)
  • BibTex
  • Text

Content

  • Citation Only
  • Citation and Abstract

Using Mathematical Modeling as a Resource in Clinical Trials

1. Department of Mathematics, Elmhurst College, 190 Prospect Avenue, Elmhurst, IL 60126

In light of recent clinical developments, the importance of mathematical modeling in cancer prevention and treatment is discussed. An existing model of cancer chemotherapy is reintroduced and placed within current investigative frameworks regarding approaches to treatment optimization. Areas of commonality between the model predictions and the clinical findings are investigated as a way of further validating the model predictions and also establishing mathematical foundations for the clinical studies. The model predictions are used to propose additional ways that treatment optimization could enhance the clinical processes. Arising out of these, an expanded model of cancer is proposed and a treatment model is subsequently obtained. These models predict that malignant cells in the marrow and peripheral blood exhibit the tendency to evolve toward population levels that enable them to replace normal cells in these compartments in the untreated case. In the case of dose-dense treatment along with recombinant hematopoietic growth factors, the models predict a situation in which normal and abnormal cells in the marrow and peripheral blood are obliterated by drug action, while the normal cells regain their growth capabilities through growth-factor stimulation.
  Figure/Table
  Supplementary
  Article Metrics

Keywords clinical trials.; leukemia; mathematical modeling; cancer

Citation: Evans K. Afenya. Using Mathematical Modeling as a Resource in Clinical Trials. Mathematical Biosciences and Engineering, 2005, 2(3): 421-436. doi: 10.3934/mbe.2005.2.421

 

This article has been cited by

  • 1. Francisco J. Solis, Sandra E. Delgadillo, Discrete mathematical models of an aggressive heterogeneous tumor growth with chemotherapy treatment, Mathematical and Computer Modelling, 2009, 50, 5-6, 646, 10.1016/j.mcm.2009.05.010
  • 2. Evans K. Afenya, Rachid Ouifki, Baba I. Camara, Suneel D. Mundle, Mathematical modeling of bone marrow – peripheral blood dynamics in the disease state based on current emerging paradigms, part I, Mathematical Biosciences, 2016, 274, 83, 10.1016/j.mbs.2016.01.010
  • 3. Urszula Ledzewicz, Heinz Schättler, Application of mathematical models to metronomic chemotherapy: What can be inferred from minimal parameterized models?, Cancer Letters, 2017, 401, 74, 10.1016/j.canlet.2017.03.021
  • 4. Urszula Ledzewicz, Heinz Schaettler, On an extension of a mathematical model for tumor anti-angiogenesis, Nonlinear Analysis: Theory, Methods & Applications, 2009, 71, 12, e2390, 10.1016/j.na.2009.05.037
  • 5. Urszula Ledzewicz, Shuo Wang, Heinz Schättler, Nicolas André, Marie Amélie Heng, Eddy Pasquier, On drug resistance and metronomic chemotherapy: A mathematical modeling and optimal control approach, Mathematical Biosciences and Engineering, 2016, 14, 1, 217, 10.3934/mbe.2017014
  • 6. Evans K. Afenya, Rachid Ouifki, Suneel D. Mundle, Mathematical Modeling of Bone Marrow – Peripheral Blood Dynamics in the Disease State Based on Current Emerging Paradigms, Part II, Journal of Theoretical Biology, 2018, 10.1016/j.jtbi.2018.10.008
  • 7. Urszula Ledzewicz, Helmut Maurer, Heinz Schättler, , Recent Advances in Optimization and its Applications in Engineering, 2010, Chapter 23, 267, 10.1007/978-3-642-12598-0_23

Reader Comments

your name: *   your email: *  

Copyright Info: 2005, Evans K. Afenya, licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution Licese (http://creativecommons.org/licenses/by/4.0)

Download full text in PDF

Export Citation

Copyright © AIMS Press All Rights Reserved